Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD

• Status: Active, not recruiting
• Trial end date: 2022-02-01
• Target enrollment: 0
• Participant gender: All

Summary

SATURN investigates the promising role of NeuroAiD in patients with spinal cord injury and will provide important information on the feasibility of conducting larger controlled trials.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Moleac Pte Ltd.

Criteria

Inclusion Criteria:

• Male or female

• Age 18 to 65 years

• Diagnosed with spinal cord injury between 3 days and 4 weeks

• American Spinal Injury Association Impairment Scale A or B

• Informed consent for inclusion into the database is obtained

Exclusion Criteria:

• Non survivable injury

• Multiple significant trauma (i.e. significant intracranial and extracranial injuries including limb fractures) that would limit observation of recovery from spinal cord injury

• Other conditions that would limit clinical assessment of outcomes (e.g. dementia, demyelinating disease, autoimmune disease, etc)

• Refusal of treatment or contraindication to NeuroAiD